fda bpc 157 category 2 bulk drug substance compounding list The U.S. Food and Administration is moving toward allowing pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC-157 just got voted in
BPC 157 just got voted in favor to be added to the 503A Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank THE PCCA BLOG FDA Guidance Explained: Compounding with Bulk Dru FDA to Remove 12 Popular Peptides from the Category 2 Do Not Compound List Frier Levitt FDA Peptide Update 2026: Removal from Do Not Compound List and What It Means for Pharmacies FDA Adds Several Peptides to Category 2 Bulks List, Restricting Them From Compounding Restore Health Consulting FDA to Review Peptides Backed by RFK Jr for Compounding Pharmacies Full story & link in the comments
Pay in 4 interest-free payments of $7.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 21 - Sep 26


